NeuroPace (NPCE) Interest & Investment Income (2021 - 2026)
NeuroPace's (NPCE) quarterly Interest & Investment Income came in at $565000.0 in Q1 2026, down 28.75% year-on-year from $793000.0 in Q1 2025, and down 11.44% quarter-over-quarter from $638000.0 in Q4 2025.
NeuroPace (NPCE) Interest & Investment Income (2021 - 2026) Analysis & Trends
NeuroPace's Interest & Investment Income history runs 6 years deep, the most recent figure standing at $565000.0 for Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 28.75% year-over-year to $565000.0 in Q1 2026; TTM through Mar 2026 was $2.6 million, a 13.44% decrease from a year earlier, with the FY2025 full-year figure at $2.8 million, down 6.88% from the prior year.
- Interest & Investment Income fell to $565000.0 in Q1 2026 per NPCE's latest filing, from $638000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $827000.0 in Q1 2024 and bottomed at $134000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $726000.0 (2023), against an average of $649000.0.
- Across the five-year window, Interest & Investment Income soared 441.79% in 2023 and dropped 28.75% in 2026, its largest moves.
- Year by year, Interest & Investment Income stood at $800000.0 in 2022, then rose by 2.75% to $822000.0 in 2023, then retreated by 17.15% to $681000.0 in 2024, then retreated by 6.31% to $638000.0 in 2025, then retreated by 11.44% to $565000.0 in 2026.
- Per Business Quant, the three latest NPCE Interest & Investment Income figures stand at $565000.0 (Q1 2026), $638000.0 (Q4 2025), and $667000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 40.98 Mn |
| 10 | NeuroPace | 517.05 Mn | 463.07 Mn | 18.05 Mn | 565,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 565,000.00 |
| Dec 31, 2025 | 638,000.00 |
| Sep 30, 2025 | 667,000.00 |
| Jun 30, 2025 | 718,000.00 |
| Mar 31, 2025 | 793,000.00 |
| Dec 31, 2024 | 681,000.00 |
| Sep 30, 2024 | 754,000.00 |
| Jun 30, 2024 | 762,000.00 |
| Mar 31, 2024 | 827,000.00 |
| Dec 31, 2023 | 822,000.00 |
| Sep 30, 2023 | 769,000.00 |
| Jun 30, 2023 | 733,000.00 |
| Mar 31, 2023 | 726,000.00 |
| Dec 31, 2022 | 800,000.00 |
| Sep 30, 2022 | 423,000.00 |
| Jun 30, 2022 | 221,000.00 |
| Mar 31, 2022 | 134,000.00 |
| Dec 31, 2021 | 186,000.00 |
| Sep 30, 2021 | 136,000.00 |
| Jun 30, 2021 | 100,000.00 |